$10.76
+0.02
(+0.19%)▲
Insights on Enhabit Inc
Revenue is down for the last 3 quarters, 275.1M → 258.3M (in $), with an average decrease of 3.1% per quarter
Netprofit is up for the last 2 quarters, -74.4M → -2.4M (in $), with an average increase of 3000.0% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 41.7% return, outperforming this stock by 68.1%
0.19%
Downside
Day's Volatility :3.33%
Upside
3.15%
33.83%
Downside
52 Weeks Volatility :57.21%
Upside
35.34%
Period | Enhabit Inc | Index (Russel 2000) |
---|---|---|
3 Months | -13.6% | 0.0% |
6 Months | -21.2% | 0.0% |
1 Year | -26.44% | -2.4% |
3 Years | -52.77% | -6.5% |
Market Capitalization | 547.9M |
Book Value | $13.51 |
Dividend Share | 0.0 |
Dividend Yield | 0.0% |
Earnings Per Share (EPS) | -3.39 |
Wall Street Target Price | 10.25 |
Profit Margin | -16.14% |
Operating Margin TTM | 3.02% |
Return On Assets TTM | 2.05% |
Return On Equity TTM | -21.27% |
Revenue TTM | 1.0B |
Revenue Per Share TTM | 21.04 |
Quarterly Revenue Growth YOY | -2.8000000000000003% |
Gross Profit TTM | 545.5M |
EBITDA | 81.8M |
Diluted Eps TTM | -3.39 |
Quarterly Earnings Growth YOY | -0.9 |
EPS Estimate Current Year | 0.18 |
EPS Estimate Next Year | 0.22 |
EPS Estimate Current Quarter | 0.07 |
EPS Estimate Next Quarter | 0.12 |
What analysts predicted
Downside of 4.74%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | - |
Net Income | 24.0M | - |
Net Profit Margin | 2.2% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 1.26% |
Net Income | 75.0M | ↑ 212.5% |
Net Profit Margin | 6.96% | ↑ 4.76% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 2.63% |
Net Income | 111.1M | ↑ 48.13% |
Net Profit Margin | 10.04% | ↑ 3.08% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 2.12% |
Net Income | 62.5M | ↓ 43.74% |
Net Profit Margin | 5.77% | ↓ 4.27% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 268.0M | ↓ 2.3% |
Net Income | 20.1M | ↓ 22.99% |
Net Profit Margin | 7.5% | ↓ 2.02% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 265.7M | ↓ 0.86% |
Net Income | 8.6M | ↓ 57.21% |
Net Profit Margin | 3.24% | ↓ 4.26% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 275.1M | ↑ 3.54% |
Net Income | 7.7M | ↓ 10.47% |
Net Profit Margin | 2.8% | ↓ 0.44% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 275.1M | ↑ 0.0% |
Net Income | 7.7M | ↑ 0.0% |
Net Profit Margin | 2.8% | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 262.3M | ↓ 4.65% |
Net Income | -74.4M | ↓ 1066.23% |
Net Profit Margin | -28.36% | ↓ 31.16% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 258.3M | ↓ 1.52% |
Net Income | -2.4M | ↓ 96.77% |
Net Profit Margin | -0.93% | ↑ 27.43% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | - |
Total Liabilities | 227.0M | - |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 6.38% |
Total Liabilities | 236.7M | ↑ 4.27% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↓ 4.33% |
Total Liabilities | 767.3M | ↑ 224.17% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↓ 6.99% |
Total Liabilities | 765.5M | ↑ 216.06% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.09% |
Total Liabilities | 108.0M | ↓ 85.89% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.4% |
Total Liabilities | 772.6M | ↑ 615.37% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.0% |
Total Liabilities | 767.3M | ↓ 0.69% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 13.33% |
Total Liabilities | 719.0M | ↓ 6.29% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 1.73% |
Total Liabilities | 742.1M | ↑ 3.21% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 59.5M | - |
Investing Cash Flow | -246.0M | - |
Financing Cash Flow | 198.2M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.9M | ↓ 58.15% |
Investing Cash Flow | -3.0M | ↓ 98.78% |
Financing Cash Flow | -16.7M | ↓ 108.43% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 123.3M | ↑ 395.18% |
Investing Cash Flow | -119.2M | ↑ 3873.33% |
Financing Cash Flow | -36.1M | ↑ 116.17% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 80.1M | ↓ 35.04% |
Investing Cash Flow | -42.3M | ↓ 64.51% |
Financing Cash Flow | -18.6M | ↓ 48.48% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 33.6M | ↓ 18.84% |
Investing Cash Flow | -2.1M | ↑ 50.0% |
Financing Cash Flow | 1000.0K | ↓ 103.73% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1000.0K | ↓ 97.02% |
Investing Cash Flow | -600.0K | ↓ 71.43% |
Financing Cash Flow | -6.2M | ↓ 720.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 310.0% |
Investing Cash Flow | -38.2M | ↑ 6266.67% |
Financing Cash Flow | 13.4M | ↓ 316.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 0.0% |
Investing Cash Flow | -3.2M | ↓ 91.62% |
Financing Cash Flow | 13.4M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.6M | ↑ 134.15% |
Investing Cash Flow | -800.0K | ↓ 75.0% |
Financing Cash Flow | -11.9M | ↓ 188.81% |
Sell
Neutral
Buy
Enhabit Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Enhabit Inc | 26.35% | -21.2% | -26.44% | -52.77% | -52.77% |
![]() Fresenius Medical Care Ag | 19.93% | -8.67% | 30.55% | -51.05% | -48.15% |
![]() Hca Holdings, Inc. | 9.31% | -6.89% | 6.72% | 62.52% | 79.28% |
![]() Universal Health Services Inc. | 4.97% | 0.07% | 6.38% | 3.88% | 3.4% |
![]() Davita Healthcare Partners Inc. | 32.47% | 5.37% | 41.69% | -3.55% | 69.22% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Enhabit Inc | 9.84 | NA | NA | 0.18 | -0.21 | 0.02 | 0.0 | 13.51 |
![]() Fresenius Medical Care Ag | 24.98 | 24.98 | 0.88 | 1.94 | 0.04 | 0.02 | 0.03 | 47.74 |
![]() Hca Holdings, Inc. | 12.47 | 12.47 | 1.31 | 18.2 | 0.21 | 0.11 | 0.01 | -9.21 |
![]() Universal Health Services Inc. | 14.46 | 14.46 | 1.87 | 10.3 | 0.11 | 0.05 | 0.01 | 88.85 |
![]() Davita Healthcare Partners Inc. | 16.2 | 16.2 | 0.43 | 7.83 | 0.34 | 0.05 | 0.11 | 13.13 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Enhabit Inc | Sell | $547.9M | -52.77% | 9.84 | -16.14% |
![]() Fresenius Medical Care Ag | Hold | $12.4B | -48.15% | 24.98 | 2.31% |
![]() Hca Holdings, Inc. | Buy | $67.5B | 79.28% | 12.47 | 9.05% |
![]() Universal Health Services Inc. | Hold | $9.4B | 3.4% | 14.46 | 4.82% |
![]() Davita Healthcare Partners Inc. | Hold | $9.5B | 69.22% | 16.2 | 5.11% |
BlackRock Inc
Vanguard Group Inc
Deerfield Management Co
JANA Partners LLC
AREX CAPITAL MANAGEMENT, LP
Cruiser Capital Advisors, LLC
Organization | Enhabit Inc |
Employees | 10000 |
CEO | Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. |
Industry | Healthcare |